PDLIM7 and nasopharyngeal carcinoma: EBV gene expression in malignant NPC cells is restricted to EBNA1, LMP1, and LMP2. Thus, the augmentation of cellular immunity to EBNA1 and LMP antigens may be a potential alternative to chemo- and radiotherapy [25].